Effects of single-dose and 1-week duration escitalopram on a stop-change task in male volunteers.
Phase of Trial: Phase II
Latest Information Update: 11 Jan 2011
At a glance
- Drugs Escitalopram (Primary)
- Indications Generalised anxiety disorder; Major depressive disorder; Obsessive-compulsive disorders; Panic disorder; Social phobia
- Focus Pharmacodynamics
- 11 Jan 2011 New trial record